evamizol effect in reducing relapse rate of nephrotic syndrome
Not Applicable
- Conditions
- nephrotic syndrome.
- Registration Number
- IRCT201106066589N2
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
idiopathic nephrotic syndrome;frequent relapses or dependency to steroid;age 1-14 years old. Exclusion criteria: the patients who consume levamizole less than 6 months;need to start other immunosupressive drugs to control the relapses.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of relapses of nephrotic syndrom. Timepoint: during the whole period of study. Method of measurement: in relapses/year.;Cumulative dose of prednisolone. Timepoint: durig the whole period of the study. Method of measurement: in mg/kg body weight/year.
- Secondary Outcome Measures
Name Time Method eutropenia. Timepoint: every 4 months. Method of measurement: CBC.;Liver enzymes elevation. Timepoint: every 4 months. Method of measurement: AST,ALT.;Seizure. Timepoint: during the study period. Method of measurement: clinical.